Trial Profile
Drug Use Investigation of YAZ
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2018
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary)
- Indications Dysmenorrhoea
- Focus Adverse reactions; Therapeutic Use
- Acronyms YAZ-DUI
- Sponsors Bayer
- 02 Apr 2018 Status changed from active, no longer recruiting to completed.
- 02 Mar 2018 Planned End Date changed from 22 Jul 2018 to 9 Mar 2018.
- 02 Nov 2017 Planned primary completion date changed from 30 Aug 2017 to 30 Nov 2017.